C. Galera-Peñaranda

Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy.

M. R. Benhnia, E. Ruiz-Mateos, M. Leal, 2014, Antiviral research.

Usefulness of the epidemiological survey and RT–PCR test in pre-surgical patients for assessing the risk of COVID-19

E. García-Vázquez, A. Hernández-Torres, C. Galera-Peñaranda, 2020, Journal of Hospital Infection.

DBP rs7041 and DHCR7 rs3829251 are Linked to CD4+ Recovery in HIV Patients on Antiretroviral Therapy

J. Benito, J. Blanco, Y. Pacheco, 2022, Frontiers in Pharmacology.